Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Pediatr. 2016 Jan 21;171:73–77. doi: 10.1016/j.jpeds.2015.12.038

Table 3.

Other laboratory data

Characteristics Fontan (n=21) Controls (n=21) P-value§
Plasma insulin, μU/mL 6.9 (3–13.4) 4.6 (1.9–6.3) 0.05
High-sensitivity CRP, mg/L 0.7 (0.3–1.0) 0.3 (0.2–0.4) 0.01
TNF-α, highly sensitive, pg/mL 1.9 (1.7–2.4) 2.2 (1.7–2.8) 0.30
Hematocrit, % 44.1 ± 2.5 36.3 ± 4.0 <.0001
Platelet count, K/μL 189 ± 80.3 245 ± 47.5 0.01
Fasting glucose 81.1 ±6.2 90.2 ± 10.5 0.002
HOMA-IR 1.3 (0.6–2.6) 1.1 (0.4–1.5) 0.15
Albumin, g/dL 4.6 ± 0.3 4.0 ± 0.3 <.0001
AST, IU/L 31.8 ± 6.3 23.9 ± 5.7 0.0001
ALT, IU/L 29.8 ± 8.1 17.5 ± 6.4 <.0001
Total bilirubin, mg/dL 0.99 ± 0.41 0.49 ± 0.23 <.0001
GGTP, IU/L 54.2 ± 24.3 10.8 ± 7.0 <.0001

Data are presented as N (%) for categorical variables and Median (IQR) or Mean ± SD for continuous variables.

§

P-value from Wilcoxon rank sum test or t-test, as appropriate, on comparison of each laboratory value between Fontan patients and healthy controls.